CA2701420C - Protective skin care tetrapeptides - Google Patents

Protective skin care tetrapeptides Download PDF

Info

Publication number
CA2701420C
CA2701420C CA2701420A CA2701420A CA2701420C CA 2701420 C CA2701420 C CA 2701420C CA 2701420 A CA2701420 A CA 2701420A CA 2701420 A CA2701420 A CA 2701420A CA 2701420 C CA2701420 C CA 2701420C
Authority
CA
Canada
Prior art keywords
peptide
skin
peptides
seq
tetrapeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2701420A
Other languages
English (en)
French (fr)
Other versions
CA2701420A1 (en
Inventor
Lijuan Zhang
Scott M. Harris
Timothy J. Falla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helix Biomedix Inc
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of CA2701420A1 publication Critical patent/CA2701420A1/en
Application granted granted Critical
Publication of CA2701420C publication Critical patent/CA2701420C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CA2701420A 2007-10-29 2008-10-28 Protective skin care tetrapeptides Active CA2701420C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81507P 2007-10-29 2007-10-29
US61/000,815 2007-10-29
PCT/US2008/012191 WO2009058244A1 (en) 2007-10-29 2008-10-28 Protective skin care tetrapeptides

Publications (2)

Publication Number Publication Date
CA2701420A1 CA2701420A1 (en) 2009-05-07
CA2701420C true CA2701420C (en) 2016-02-09

Family

ID=40305326

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2701420A Active CA2701420C (en) 2007-10-29 2008-10-28 Protective skin care tetrapeptides

Country Status (9)

Country Link
US (1) US8071555B2 (https=)
EP (1) EP2205623B1 (https=)
JP (1) JP5379806B2 (https=)
KR (1) KR101668803B1 (https=)
CN (1) CN101855235B (https=)
CA (1) CA2701420C (https=)
ES (1) ES2567706T3 (https=)
PL (1) PL2205623T3 (https=)
WO (1) WO2009058244A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168181B2 (en) * 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2822302A1 (en) * 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
ES2421262T3 (es) * 2007-11-30 2013-08-30 Evonik Goldschmidt Gmbh Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
EP2723363B1 (en) 2011-06-24 2018-08-29 NoNO Inc. Combination therapy for ischemia
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
EP2838547B1 (en) * 2012-04-16 2019-09-04 Lubrizol Advanced Materials, Inc. Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
HK1210192A1 (en) 2012-07-19 2016-04-15 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
CN105324122B (zh) * 2013-06-14 2019-08-27 赫里克斯生物医疗公司 可用于治疗多种皮肤病的衍生自人类c-x-c趋化因子的四肽
KR20150130616A (ko) * 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
US9351911B1 (en) 2015-07-30 2016-05-31 Truth Aesthetics LLC Topical skin care composition providing broad spectrum sunscreen
US9636292B2 (en) 2015-07-30 2017-05-02 Truth Aesthetics LLC Topical skin care composition for night use
CN107629111B (zh) * 2017-10-26 2021-06-04 陕西慧康生物科技有限责任公司 一种乙酰基四肽-2的液相合成方法
CN113166205A (zh) * 2018-11-30 2021-07-23 英特肽治疗有限公司 用于改善皮肤病状的多肽和方法
KR102120992B1 (ko) * 2019-05-03 2020-06-10 (주)위바이오트리 신규한 금속 층상수산화물 복합체 및 이의 제조방법
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
KR102778423B1 (ko) * 2019-09-26 2025-03-10 (주)아모레퍼시픽 피부 각질세포의 항노화 물질 스크리닝 방법, 스크리닝 키트 및 피부 각질세포의 항노화 물질 함유 조성물
EP4001294A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
FR3123193B1 (fr) * 2021-05-28 2025-11-07 Oreal Procédé d’électroporation pour délivrer une composition comprenant au moins un peptide de poids moléculaire allant de 500 Da à 20 kDa
US20250268807A1 (en) * 2022-04-27 2025-08-28 Sbla Brands Inc. Anti-aging peptide containing cosmetic
CN121717873A (zh) * 2026-02-24 2026-03-24 中国医学科学院药用植物研究所 具有祛痘护肤作用的貂肽化合物及其分离制备

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1357121A (en) * 1970-07-28 1974-06-19 Squibb & Sons Inc Peptide enzyme inhibitors
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
JP2820750B2 (ja) 1988-04-21 1998-11-05 ユーエービー リサーチ ファウンデイション 創傷治療部位における癒着の発生からの保護に適するバイオエラストマー材料
CA2032527C (en) 1989-04-10 2002-07-02 Jesse M. Jaynes Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5464820A (en) 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
US5763576A (en) 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
FR2741076B1 (fr) 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
EP0858808B1 (en) 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
GB9702943D0 (en) 1997-02-13 1997-04-02 Univ Manchester Wound healing
SE9701162D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
US6143742A (en) 1997-12-11 2000-11-07 Fuisz Technologies Ltd Treatment for necrotizing infections
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6344189B1 (en) 1998-04-01 2002-02-05 Biotech Australia Pty., Ltd. Use of protease inhibitors for treating skin wounds
US6096327A (en) 1998-11-05 2000-08-01 Protease Sciences Inc. Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
CA2312075A1 (en) 1998-11-05 2001-12-22 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
FR2788777B1 (fr) 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6537968B1 (en) 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
GB0029777D0 (en) 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
CA2441562C (en) 2001-03-28 2013-05-14 Helix Biomedix, Inc. Short bioactive peptides and methods for their use
WO2002092623A1 (en) * 2001-05-11 2002-11-21 Research Development Foundation INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
US20040167072A1 (en) 2001-05-11 2004-08-26 Aggarwal Bharat B. Inhibitors of receptor activator of NF-kappaB and uses thereof
US7238656B2 (en) 2001-08-29 2007-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
US7041506B2 (en) 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
EP1534308A4 (en) 2001-11-28 2007-03-14 Becton Dickinson Co PEPTIDES WITH INHIBITORY ACTION OF GROWTH
US20040009911A1 (en) 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
US7491691B2 (en) 2002-05-03 2009-02-17 Sindrey Dennis R Connective tissue stimulating peptides
US7265097B2 (en) 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US7541440B2 (en) 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
EP1686957B1 (en) 2003-11-17 2012-03-07 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
DE102004050563A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
DE102005000868A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
DE102004055541A1 (de) 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
US7271239B2 (en) 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
WO2006028993A2 (en) 2004-09-02 2006-03-16 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US20070224150A1 (en) 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
JP4846799B2 (ja) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
US20070077305A1 (en) 2005-10-03 2007-04-05 Le Tien C Biocompatible polymeric matrix and preparation thereof
DE102005063062A1 (de) 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
EP2537932B1 (en) * 2006-02-21 2016-04-27 President and Fellows of Harvard College Compositions for and methods of identifying antigens

Also Published As

Publication number Publication date
CN101855235B (zh) 2013-04-24
CA2701420A1 (en) 2009-05-07
KR20100083828A (ko) 2010-07-22
EP2205623A1 (en) 2010-07-14
JP5379806B2 (ja) 2013-12-25
KR101668803B1 (ko) 2016-10-24
HK1146070A1 (zh) 2011-05-13
JP2011502121A (ja) 2011-01-20
PL2205623T3 (pl) 2016-09-30
ES2567706T3 (es) 2016-04-26
US8071555B2 (en) 2011-12-06
WO2009058244A1 (en) 2009-05-07
CN101855235A (zh) 2010-10-06
EP2205623B1 (en) 2016-03-16
US20090142280A1 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
CA2701420C (en) Protective skin care tetrapeptides
CN102317307B (zh) 用于治疗和/或护理皮肤、粘膜和/或头皮的肽及它们在美容组合物或药物组合物中的用途
JP7010823B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアにおいて有用な化合物
ES2399581T3 (es) Composiciones cosméticas o farmacéuticas que comprenden inhibidores de metaloproteinasa
ES2228500T3 (es) Extracto ppeptidico de lupino y composicion farmaceutica o cosmetica o nutraceutica que comprende dicho extracto.
ES2397889B1 (es) PÉPTIDOS MODULADORES DE PGC-1Alfa.
US20240352069A1 (en) Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
KR20200024235A (ko) 피부, 모발, 손톱 및/또는 점막의 치료 및/또는 관리에 유용한 화합물
US20150031633A1 (en) Bifunctional peptide
AU2007342353B2 (en) Short bio-active peptides for cellular and immunological modulation
KR101764171B1 (ko) 자외선 광 독성에 대한 펩티드 보호
KR101753874B1 (ko) 데카펩타이드를 유효성분으로 포함하는 화장료 조성물
US20230255873A1 (en) Cosmetic or dermatological peptide-based treatment of the skin and its integuments
CN118206619A (zh) 环九肽及其组合物和用途
HK1146070B (en) Protective skin care tetrapeptides
RU2853306C2 (ru) Синтетический пептид и его косметическая или фармацевтическая композиция и применение
KR20190056106A (ko) 창상 치료제로서의 펩타이드의 용도
KR20190056110A (ko) 창상 치료제로서의 펩타이드의 용도
HK1170419B (en) Peptide protection against ultraviolet light toxicity
HK1162540B (en) Peptides for use in cosmetic or pharmaceutical treatment of the skin, mucous membranes and/or scalp

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130610

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240905

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240905

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240905

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250902

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250902